Novel Coronavirus Cough Database: NoCoCoDa by Cohen-Mcfarlane, M. (Madison) et al.
This work is licensed under a Creative Commons Attribution 4.0 License. For more information, see https://creativecommons.org/licenses/by/4.0/.
This article has been accepted for publication in a future issue of this journal, but has not been fully edited. Content may change prior to final publication. Citation information: DOI
10.1109/ACCESS.2020.3018028, IEEE Access
 
VOLUME XX, 2017 1 
Date of publication xxxx 00, 0000, date of current version xxxx 00, 0000. 
Digital Object Identifier 10.1109/ACCESS.2017.Doi Number 
Novel Coronavirus (2019) Cough Database: 
NoCoCoDa 
Madison Cohen-McFarlane1, IEEE Student Member, Rafik Goubran1,2, IEEE Fellow, and 
Frank Knoefel1,2,3 
 
1Department of Systems and Computer Engineering, Carleton University, 1125 Colonel By Drive, Ottawa, ON, Canada.  
2Bruyére Research Institute, 43 Bruyère Street, Ottawa, ON, Canada. 
3Physician at Bruyère Continuing Care and Elisabeth Bruyère Hospital, 43 Bruyère Street, Ottawa, ON, Canada 
Corresponding author: Madison Cohen-McFarlane (e-mail: madison.mcfarlane@sce.carleton.ca). 
This work was supported by AGE-WELL NCE Inc., a member of the Networks of Centers of Excellence program, a Government of Canada program and the 
support of the Natural Sciences and Engineering Research Council of Canada (NSERC). 
ABSTRACT The current pandemic associated with the novel coronavirus (COVID-19) presents a new area 
of research with its own set of challenges. Creating unobtrusive remote monitoring tools for medical 
professionals that may aid in diagnosis, monitoring and contact tracing could lead to more efficient and 
accurate treatments, especially in this time of physical distancing. Audio based sensing methods can address 
this by measuring the frequency, severity and characteristics of the COVID-19 cough. However, the 
feasibility of accumulating coughs directly from patients is low in the short term. This paper introduces a 
novel database (NoCoCoDa), which contains COVID-19 cough events obtained through public media 
interviews with COVID-19 patients, as an interim solution. After manual segmentation of the interviews, a 
total of 73 individual cough events were extracted and cough phase annotation was performed. Furthermore, 
the COVID-19 cough is typically dry but can present as a more productive cough in severe cases. Therefore, 
an investigation of cough sub-type (productive vs. dry) of the NoCoCoDa was performed using methods 
previously published by our research group. Most of the NoCoCoDa cough events were recorded either 
during or after a severe period of the disease, which is supported by the fact that 77% of the COVID-19 
coughs were classified as productive based on our previous work. The NoCoCoDa is designed to be used for 
rapid exploration and algorithm development, which can then be applied to more extensive datasets and 
potentially real time applications. The NoCoCoDa is available for free to the research community upon 
request.  
INDEX TERMS Acoustic signal processing, audio databases, audio systems, biomedical measurement, 
biomedical monitoring, data analysis, data collection, medical conditions, medical diagnosis, patient 
monitoring, smart homes.  
I. INTRODUCTION 
On March 11th, 2020 the World Health association (WHO) 
declared the rapid transmission of the novel coronavirus 
(COVID-19) a pandemic [1]. Since then researchers around 
the world have been working to aid in the diagnosis, tracking 
and treatment of all those affected [2]–[5]. As of June 18th, 
2020, there have been a total of 10,021, 401 cases worldwide 
(103,250 Canada) and 499,913 deaths (8,522 Canada) [1] [6]. 
With so many people affected, novel methods for disease 
predication and tracking should be considered.  
The symptoms of COVID-19 vary considerably depending 
on the individual and their expression can take up to 14 days 
to present after an individual is affected [6]. Furthermore, the 
early symptoms are easily confused with those of the common 
cold and/or flu (cough, fatigue and fever) [6]. If the virus 
enters the lungs, it can lead to difficulty breathing, pneumonia 
and possibly death [6].  
Early identification, prior to infection moving to the lungs, 
would be an important tool in early identification for testing, 
isolation and contact tracing. Cough signature identification 
may help differentiate between coughs caused by various 
viruses, bacteria, or other acute and chronic health conditions. 
This cough signature could then be used as a screening method 
at airports, borders and health facility waiting rooms. 
This work is licensed under a Creative Commons Attribution 4.0 License. For more information, see https://creativecommons.org/licenses/by/4.0/.
This article has been accepted for publication in a future issue of this journal, but has not been fully edited. Content may change prior to final publication. Citation information: DOI
10.1109/ACCESS.2020.3018028, IEEE Access
 
VOLUME XX, 2017 9 
Furthermore, a monitoring method that harnesses currently 
available technology would allow for the acquisition of larger 
amounts of data. As one of the early symptoms of COVID-19 
is cough [1], here we introduce the idea of using audio 
recordings of cough events as an area for further investigation. 
The long-term goal being the development and 
implementation of a system that can ideally monitor, detect 
and classify cough events.  
Currently physicians asses cough based on the frequency 
(how often someone coughs), severity (how forceful the cough 
event is), and cough characteristics based on known cough 
types (wet, dry, wheeze, and whooping). The available 
information to the physician is limited as they tend to rely on 
clinical observations and self-reporting from the patient. This 
is exacerbated by the current pandemic with physical 
distancing and isolation leading to infrequent medical visits, 
which makes efficient and accurate diagnosis difficult.  
Unobtrusive cough assessment methods have a few possible 
applications. An audio-based assessment tool could be 
implemented in residential environments as a subsystem of 
current remote health monitoring systems (e.g.  Safety Labs 
[7]). The same tool could be implemented, with adjustments, 
to large public spaces like waiting rooms and transit stations. 
Here, the main goal would be track individuals who are 
experiencing coughs associated with a particular disease (e.g. 
COVID-19) in order to help with contact tracing. Finally, the 
system could also be implemented in continuing care homes 
by providing more accurate clinical information about the 
frequency and severity of cough events to medical 
professionals.  
When considering COVID-19 type cough events, the 
largest hurdle is the collection of coughs from those testing 
positive with COVID-19. As of now, the feasibility of a 
clinical study aimed to record involuntary cough events from 
COVID-19 positive individuals is unrealistic. This is 
especially true when considering the time it would take to 
accumulate this kind of data, not to mention adding more 
pressure to the healthcare system by adding more work for 
frontline workers. Additionally, taking a blood sample or an 
X-ray is much easier than asking frontline workers to get a 
patient in distress to cough on demand and record it. A clinical 
study may be possible in the future, but not during an active 
state of pandemic.  
Alternative methods of data collection can be considered in 
order to start investigating the feasibility of using the audio of 
coughs as a tool to identify COVID-19. Recently two research 
groups have focused on asking individuals to record their 
coughs at home. Cambridge University published an app 
called COVID-19 Sounds App [8], the goal of which is to ask 
individuals, both healthy and unhealthy (COVID-19 positive), 
to record their cough and breathing events. They also collect 
basic demographics, medical history and a voice sample [8]. 
A group out of L’École Polytechnique Fédérale de Lausanne 
has created a web-based application, which asks users who 
have self-reported to have COVID-19 to record cough events 
using their smartphone [9]. Additional information requested 
includes any other symptoms experienced by the user [9]. 
Both applications ask users to cough into the microphone on 
their device, the recorded coughs would therefore be voluntary 
in nature. There are key pathophysiological differences 
between voluntary and reflex cough events [10]. It has also 
been reported that these two mechanisms are affected 
differently by disease [10]. As COVID-19 research is in the 
early days, we don’t know if it affects these types of cough 
events differently.  
Furthermore, there are vast repositories of information 
available online. Creating tools to harness this pre-existing 
information to investigate new ideas can be considered an 
implementation of big data research, which is a growing area 
of interest [11]. Some areas of big data research include 
sourcing data from social media [12] and YouTube videos 
[13]. More recently, researchers have focused on using big 
data information to evaluate trends in the current COVID-19 
pandemic [12], [14], [15]. 
To our knowledge there are no cough databases currently 
available that contain reflex COVID-19 cough events. Here 
we present the Novel Coronavirus Cough Database 
(NoCoCoDa), that have been collected through online 
interviews with COVID-19 positive individuals as an 
unobtrusive and noncompulsory source of COVID-19 cough 
events. 
 
II. EXISTING AUDIO COUGH EVENT DATABASES IN 
THE LITERATURE 
There are very few databases of audio-based cough events 
currently available.  There are however online databases that 
include cough events as a class of audio events. This means 
that the cough events do not necessarily contain additional 
information (e.g. demographics or disease information). 
Databases available for use that include cough events are as 
follows. 
A. Audio Set 
Database of audio events from 632 audio classes collected 
from 10 second segments of YouTube videos. There are 871 
cough events and 834 breathing events. There are no further 
descriptions other than segments being labeled as a cough 
[16]. 
B. DCASE 2016 
DCASE 2016 or detection and classification of acoustic 
scenes and events was a challenge presented in 2016. The 
second task, sound event detection in synthetic audio, 
contained 20 cough events [17]. Again, these cough events did 
not contain any other descriptions or labels.  
C. Freesound 
Freesound.org is a free access collaborative collection of 
sounds [18]. As sounds are collected from many users, 
recording methods and descriptions vary significantly. When 
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searching for the term ‘cough’, 736 sounds were identified 
[18], none of which included any other descriptions or labels. 
D. Targeted cough research 
When looking for a cough specific database, not many are 
available and even less are free to use. The only one that was 
found was a collection of cough events compiled from online 
sources used to evaluate Pertussis [19]. The coughs used were 
not released as a stand-alone database, however the original 
links were included as a table in the publication. For 
completeness, all links were tested and only 23 of the listed 38 
were still available. The coughs used in the Pertussis paper 
included a disease type and age group (infant, child or adult).  
Our research group has worked with audio cough events in 
the past using both a curated collection of cough events [20], 
[21] and pre-existing databases [22]. The curated collection of 
cough events were obtained from sound database [20], 
personal cough recordings and a subset of cough events 
included in Smith et. al. [23].  
III. PROPOSED DATABASE: NoCoCoDa 
A. Interview Acquisition 
The database of novel coronavirus coughs (NoCoCoDa) 
contain cough events obtained from online interviews with 
COVID-19 positive individuals. All interviews were found 
online and were published by news sources. Searches were 
conducted from April to June 2020, in order to identify any 
new interviews. Search terms used are listed in Table I and 





1. Coronavirus interview 
2. Coronavirus infected person interview 
3. Coronavirus interview from hospital 
4. Coronavirus interview from ICU 
5. COVID interview 
6. COVID-19 interview 
7. Interview with COVID-19 patient 
 
A total of 13 interviews were found involving 10 individuals. 
Interview information is summarized in Table II.  
B. Cough segmentation 
For each interview, cough events were manually segmented 
and assigned a label (C19_subjectNumber_coughNumber). 
Each file was then saved as a WAV file with a sampling rate 
of 44.1kHz. This resulted in 73 individual cough events. As 
these were cough events extracted from interviews, some 
contained background noise (i.e. speech or music). 
Additionally, some of the events were a mix between a throat 
clear and a cough event, which are labeled in the 
supplementary file. The supplementary file 
‘coughDescriptions.txt’ is included with nine columns (Name; 
Duration (s); Number of Phases; Phase Notes; Competing 
Sources; Sex; Age; Live vs. Home (as described in section IV; 
Notes (including any self-reported underlying conditions)).  
C. Cough phase annotation 
There are three phases in a typical cough event [10][23]. These 
phases are typically called the (1) initial cough sound, (2) 
intermediate phase, and (3) second cough sound [23]. Figure 
1 presents an example COVID cough event with each phase 
identified. The underlying physiology behind these phases are 
outside the scope of this paper, however a detailed description 
can be found in [10]. 
Identification and labeling of these three phases in a cough 
event may highlight differences between types of cough 
events. For example, Chatrzarrin et al. used the power 
variations between the first and second phase as a feature for 
differentiating between wet and dry cough events. 
Furthermore, some cough events do not contain the third phase 
(Figure 2) [23]. The reduction or complete absence of this 
phase may also be a potential tool for differentiation. 
 
FIGURE 1.  COVID-19 cough event from S1 with all phases present 
(filename = C19_1-1.wav). 
 
FIGURE 2.  COVID-19 cough event from S2 with only two phases 
(filename = C19_2-5.wav).  
For each cough event in NoCoCoDa, the two or three phases 
were annotated with time stamps. The annotations are 
included in a supplementary file ‘phaseAnnotations.txt’. 
There are five columns, cough event name, the start of each 
phase and the end of phase three if present. There is an 
assumption that consecutive phases occur immediately after 
one another. If there is no third phase present, the beginning 
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TABLE II 















Coronavirus Patient Speaks 








2 Male, no underlying health conditions, 
COVID-19 positive 
S1 
COVID-19 patient ‘would 
beg’ Canadians to obey top 
doctors, government 






15 Female, 28 during the 10th 
symptomatic day  
S2 
DocMom Describes 









13 Male child (four years old) S3 
Georgia coronavirus 
patient talks about what it’s 













3 Male self-reporting as also having 
pneumonia and diabetes 
S4 
He’s Infected. See his 






















1 Female adult S6 
Like glass in your lungs 
Woman survives 
coronavirus after ICU 










5 Female 30 something S7 = S11 
Ohio man shares 
coronavirus experience | 
ABC News 





2 Male 56 S8 = S9 












1 Male 56 S9 = S8 
What it’s like having 








7 Female 40 something S10 
Woman in ICU warns of 
Covid-19 dangers ‘Don’t 










6 Female S11 = S7 
Judy Gabriel Interview – 













COVID-19 survivor still 
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of phase three was set at the end of phase two and the end of 
phase three was set to zero. In the case where the cough event 
included some component of a throat clear, only a single phase 
was identified by the bounds of ‘start of phase 1’ and end of 
phase 1’, the remaining columns were set to zero. Table III 
contains a subset of some of the annotations.  
 
TABLE III 














C19_1-1.wav 0.058 0.042 0.163 0.447 
C19_1-2.wav 0.126 0.354 0.470 0.534 
⋮ ⋮ ⋮ ⋮ ⋮ 
⋮ ⋮ ⋮ ⋮ ⋮ 
C19_13-2.wav 0.114 0.206 0.428 0.490 
C19_13-3.wav 0.045 0.107 0.256 0.364 
 
IV. COVID-19 COUGH CHARACTERISTICS 
The cough associated with COVID-19 has been reported to be 
dry (non-productive) in the early phases of the disease [1], [6]. 
More recently however, there has been some reports indicating 
that the cough becomes more productive (wet) as the disease 
begins to affect the lungs [24].  
From pathophysiological perspective, the presentation of 
both cough events can be explained. Once an individual is 
exposed to the COVID-19 virus it enters their system either 
through the mucus membrane or blood [25]. The virus then 
uses the angiotensin-converting enzyme 2 (ACE-2) receptor 
to enter the body cells [25]. 
The inhibition of the ACE-2 receptor due to the COVID-19 
virus using it has a similar reaction in the body as individuals 
who take ACE-Inhibitors to treat heart conditions [26]. It has 
been reported that in a minority of patients who use these 
medications have a non-immune type-B hypersensitivity 
reaction that causes a chronic dry cough [26].  
Once the virus enters a cell, it creates more viral proteins 
and viral RNA, which are packaged and released in order to 
attach to other cells with the ACE-2 receptors within the body 
[25]. Once the virus has affected lungs, the body will send 
neutrophils (white blood cells) to that area and release reactive 
oxygen species and cytokines [25]. This buildup of white 
blood cells is an inflammatory response, and depending on its 
severity can lead to the production of sputum, making it a  
productive cough [27]. Depending of the contents of the 
sputum, there could also be destruction of lung tissue (blood) 
and secondary infection of bacteria[28].  
This possible transition from a dry to wet cough is notable 
among diseases with cough as a symptom. Therefore, cough 
progression among COVID-19 positive individuals may 
provide insight to diagnosis and disease progression as not 
everyone with COVID-19 will present with the more severe 
reaction that may be associated with productive cough events.  
In this dataset, we have no definitive cough progression 
information. However, there are four subject interviews 
(5,7,8/9, 12/13) where an at home video (typically when they 
were hospitalized) of coughing was played in addition to live 
coughing events. Therefore, for these four subjects, there is at 
least one cough event from a more severe stage (home video) 
of the disease and at least one cough event from the recovery 
stage of the disease (live interview). These cough events were 
labeled as either ‘home’ or ‘live’ in the description file 
(column eight). 
Unfortunately, we do not have access to cough events at the 
beginning of the disease progression, prior to the expression 
of more severe symptoms and/or hospitalizations. We 
therefore expect that at least some of the cough events present 
in this dataset will be more productive (wet) in nature due the 
time at which they were recorded in the disease progression. 
Future data collection focusing on the progression from dry 
(early stages) to wet (later stages in severe cases) may lead to 
some findings that are unique for COVID-19.   
V. COUGH DETECTION  
The progression of cough is a clinical indicator of disease 
progression and deterioration [23]. Cough detection from 
audio recordings is a growing area of research that may be able 
to support medical professionals especially in the current 
period of physical distancing. Detection can be considered 
from two different perspectives.  
Cough detection amongst other sounds (sometimes referred 
to as cough identification) can lead to a measure of cough 
frequency. Hoyos-Barceló et.al. implemented a cough event 
detection tool in real time using smartphone recordings. Their 
approach used a k-NN classifier with accuracies of 93% [29]. 
In [30] coughs were classified based on 8-dimentional number 
octonions. Classification of cough sounds vs. non-cough 
sounds using this method resulted in a sensitivity of 96% and 
a specificity of 98.4% [30]. Monge-Álvarez et.al. applied 
moment theory to detect cough events in noisy audio signals, 
which resulted in a sensitivity and specificity of about 90% 
[31].  
The monitoring of human sounds (e.g. snoring) throughout 
the night is a related area of research. Vhaduri et.al. have 
investigated cough and snore detection in the presence of 
ambient room noise using smartphones. The k-NN classifier 
resulted in the highest accuracy (97%) when performing the 
binary classification between  cough and snore events [32]. 
Voluntary cough detection against speech in a population of 
volunteers has also been investigated [33]. The authors used a 
classification tree to differentiate between cough and non-
cough events resulting in a sensitivity of 100 % and a 
specificity of 95% [33].  
The second cough detection perspective focuses on disease 
and or cough type differentiation. Here, it is assumed that 
cough events have previously been identified and further 
investigation into audio cough characteristics is needed for 
diagnosis and/or monitoring purposes. This area has received 
considerably less research and a fully automatic cough-based 
diagnosis tool has not been adopted in the medical field. 
However, Pramono et.al. has created a cough-based algorithm 
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automatic diagnosis of pertussis, more commonly known as 
whooping cough [34]. The focus of this algorithm is the 
differentiation between the classical whooping sound and all 
other events in a cough recording using a logistic regression 
model [34]. Among 38 patients, pertussis was diagnosed with 
100% accuracy with zero false diagnosis. They also report that 
individual cough sounds were detected with a 92% accuracy 
[34].  
Most of the aforementioned research focuses on a binary 
classification task between cough and non-cough related 
sounds (i.e. speech, ambient room noise and snore). A more 
complex problem is the differentiation between different 
cough types, which was evaluated in [34] to evaluate 
whooping sounds. Two very similar cough types that have 
clinical relevance is productive (wet) and non-productive (dry) 
cough types. The majority of research into productive vs. non-
productive cough sounds has focused on feature evaluation 
[20], [35]. 
The COVID-19 cough has generally been reported as non-
productive (dry). However, in severe cases the cough can 
progress and become more productive in nature. The 
following section describes the implementation of our 
previously created cough type detection tools to the 
NoCoCoDa, highlighting the fact that the majority of the 
cough events in the database were recorded at later stages of 
the disease. This is the first step in the differentiation between 
COVID-19 cough events and non-COVID-19 cough events, 
which is outside the scope of the current paper.  
VI. COVID-19 COUGH TYPE DETECTION 
As mentioned, the cough associated with COVID-19 can be 
dry during early stages and progress to become more 
productive as the disease progresses in a subset of severely 
affected individuals [24]. It is important to note that a single 
cough is rarely completely dry or completely wet. The lack of 
a clear separation leads to inconsistencies when coughs are 
being labeled by physicians. Therefore, it may be more 
accurate to say that a particular cough is more wet or dry in 
nature.  
Our research group has previously investigated the 
differentiation of these two cough types [20]. We applied the 
methods described in Chatrzarrin et al. to the COVID-19 
dataset in order to investigate if these coughs were identified 
as dry or wet cough events. The two features used were 
number of peaks present in the energy spectrum and the power 
ratio between the first two phases of each cough event [20]. 
We extended this work by creating a Linear Discriminant 
Analysis (LDA) classifier to differentiate between wet and dry 
cough events using our previously used data [20]. We then 
classified the COVID-19 events to detect if they were more 
wet or dry in nature.  
 We expected that some of the cough events, especially those 
recorded during hospitalization, were more likely to be wet 
given the more severe impact on the lungs. The results in 
Figure 3 indicate that the majority of cough events from the 
NoCoCoDa database have been identified as more wet like 
based on the low power ratio and higher number of peaks 
present in the energy spectrum. More specifically, after 
classification with the LDA, 77% of the COVID-19 cough 
events were identified as wet. This further supports our 
hypothesis that most of the cough events were from 
individuals with severe cases of the disease.  
 
FIGURE 3.  Power ratio vs. number of peaks feature comparison of 
COVID-19 coughs when compared to the wet and dry coughs events 
from [20]. 
VII. CURRENT ISSUES WITH THE DATASET 
The NoCoCoDa contains COVID-19 cough events that were 
obtained from online sources. Though using this dataset may 
be very beneficial for early research, the end goal would be to 
collect a more controlled dataset of COVID-19 cough events 
and apply the early methods designed using NoCoCoDa to the 
new data.  
 We have identified some of the issues associated with the 
current iteration of this dataset, which are as follows.  
A. Inconsistent recording methods 
Recording methods are unknown in all cases. Interviewees are 
presented via online video chat, which may introduce 
additional recording errors. At home videos of patients during 
severe stages of the disease are also presented and recording 
methods are also unknown.  
B. Competing sources 
As the cough events were taken from interviews, there are 
periods where multiple individuals are speaking. Sometimes 
cough events are present with speech from the interviewer. 
There are also a few cases, where music was overlaid over 
speech or an at home video of cough events.  
C. Self report labeling methods 
All of the cough events in NoCoCoDa are labeled based on the 
assumption that they are indeed interviews with COVID-19 
positive individuals. Additionally, all interviews presented 
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were from news sources and assumed that they have 
previously done their own due diligence.  
 There are a few recordings where the interviewee disclosed 
that they have underlying conditions. Those labels have also 
been included here, but again are based on the assumption that 
interviewees are correct.  
 Though most of the live interviews indicated that they were 
done after the interviewee has recovered to some extent, we 
do not know how severe their lung involvement was for either 
the live or home cough events. Furthermore, the disease stage 
for the home videos, often recorded while interviewees were 
in hospital, is also unknown.  
D. Small and inconsistent sample size 
NoCoCoDa is restricted by the available resources, meaning 
that there have only been 11 subjects identified. Furthermore, 
the number of cough events per subject varies considerably as 
every cough event was a reflex cough.  
VIII. CONCLUSIONS 
Here we have presented the NoCoCoDa of 73 COVID-19 
reflex cough events. The collection of the data from 
identification of interviews with COVID-19 positive 
individuals to manual cough segmentation. Furthermore, we 
have described the supplementary files that include cough 
event descriptions and cough phase annotations.  
 COVID-19 coughs have a notable pathophysiology, 
specifically how they may transition from a dry cough (one of 
the most common symptoms) to a more productive (wet) 
cough in severe cases of the disease. We highlighted this by 
applying our previous feature comparison method aimed to 
differentiate between wet and dry cough events. The majority 
(77%) of COVID-19 cough events have been identified as 
being more wet in nature, indicating that the interviewees were 
probably in the subset of patients who had more severe 
reactions and recordings were done during that time.  
Finally, we have discussed some of the short falls of this 
dataset including; inconstant recording methods, competing 
sources, self-report labeling methods and small and 
inconsistent sample sizes. We present this dataset as a 
preliminary tool to create possible COVID-19 cough 
identification and tracking tools that may later be applied to a 
more through dataset. The long-term goal is to implement 
tools derived using NoCoCoDa in unobtrusive monitoring 
environments (residential, public and continuing care homes) 
to monitor the frequency, severity and cough characteristics in 
order to aid contract tracing of disease and provide medical 
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